ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
The evolutionary trajectory of epigenomics in adult glioma (2021)
Datta, Indrani; Pereira, Tathiane Maistro Malta; Sabedot, Thais Sarraf; She, Ruicong; Iavarone, Antonio; Noushmehr, Houtan; Poisson, Laila M.
Source: Cancer Research. Conference titles: AACR Annual Meeting 2021. Unidades: FCFRP, FMRP
Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL, DADOS DE SEQUÊNCIA MOLECULAR, GENOMAS, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DATTA, Indrani et al. The evolutionary trajectory of epigenomics in adult glioma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2085. Acesso em: 10 maio 2024. , 2021
APA
Datta, I., Pereira, T. M. M., Sabedot, T. S., She, R., Iavarone, A., Noushmehr, H., & Poisson, L. M. (2021). The evolutionary trajectory of epigenomics in adult glioma. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2085
NLM
Datta I, Pereira TMM, Sabedot TS, She R, Iavarone A, Noushmehr H, Poisson LM. The evolutionary trajectory of epigenomics in adult glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2085
Vancouver
Datta I, Pereira TMM, Sabedot TS, She R, Iavarone A, Noushmehr H, Poisson LM. The evolutionary trajectory of epigenomics in adult glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2085
Trabalho de evento-resumo periodico
Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma (2021)
Varn, Frederick; Johnson, Kevin C.; Barthel, Floris P.; Kim, Hoon; Wade, Taylor; Lodha, Disha; Ajaib, Shoaib; Ahmed, Nazia; Garofano, Luciano; D'Angelo, Fulvio; Stead, Lucy; Noushmehr, Houtan; Iavarone, Antonio; Verhaak, Roel
Source: Cancer Research. Conference titles: AACR Annual Meeting 2021. Unidade: FMRP
Subjects: GLIOMA, DERIVA GÊNICA, SISTEMA IMUNE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2169. Acesso em: 10 maio 2024. , 2021
APA
Varn, F., Johnson, K. C., Barthel, F. P., Kim, H., Wade, T., Lodha, D., et al. (2021). Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2169
NLM
Varn F, Johnson KC, Barthel FP, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D'Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2169
Vancouver
Varn F, Johnson KC, Barthel FP, Kim H, Wade T, Lodha D, Ajaib S, Ahmed N, Garofano L, D'Angelo F, Stead L, Noushmehr H, Iavarone A, Verhaak R. Tumor-myeloid cell interactions are dynamic and influence the evolutionary trajectory of adult diffuse glioma [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2169
Artigo de periodico
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma (2021)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sanson, Marc; Wick, Wolfgang; Brandes, Alba; Clement, Paul M.; Erridge, Sara C.; Vogelbaum, Michael A.; Nowak, Anna; Baurain, Jean; Mason, Warren P.; Wheeler, Helen; Chinot, Olivier L.; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taal, Walter; Rudà, Roberta; Weller, Michael; McBain, Catherine; Linde, Myra E. van; Sabedot, Thais S.; Hoogstrate, Youri; Deimling, Andreas von; Heer, Iris de; IJcken, Wilfred F. J. van; Brouwer, Rutger W. W.; Aldape, Kenneth; Jenkins, Robert B.; Dubbink, Hendrikus; Kros, Johan M.; Wesseling, Pieter; Cheung, Kin Jip; Golfinopoulos, Vassilis; Baumert, Brigitta; Gorlia, Thierry; Noushmehr, Houtan; French, Pim
Source: Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, GLIOMA, MUTAÇÃO, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, v. 23, n. 9, p. 1547-1559, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab088. Acesso em: 10 maio 2024.
APA
Tesileanu, C. M. S., Van den Bent, M., Sanson, M., Wick, W., Brandes, A., Clement, P. M., et al. (2021). Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, 23( 9), 1547-1559. doi:10.1093/neuonc/noab088
NLM
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab088
Vancouver
Tesileanu CMS, Van den Bent M, Sanson M, Wick W, Brandes A, Clement PM, Erridge SC, Vogelbaum MA, Nowak A, Baurain J, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Linde ME van, Sabedot TS, Hoogstrate Y, Deimling A von, Heer I de, IJcken WFJ van, Brouwer RWW, Aldape K, Jenkins RB, Dubbink H, Kros JM, Wesseling P, Cheung KJ, Golfinopoulos V, Baumert B, Gorlia T, Noushmehr H, French P. Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1547-1559.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab088
Trabalho de evento-resumo periodico
Glioma immune microenvironment change during tumor recurrence (2021)
Pereira, Tathiane Maistro Malta; Datta, Indrani; Sabedot, Thais; She, Ruicong; Castro, Ana Valéria; Iavarone, Antonio; Poisson, Laila M.; Noushmehr, Houtan
Source: Cancer Research. Conference titles: AACR Annual Meeting 2021. Unidades: FCFRP, FMRP
Subjects: GLIOMA, GENOMAS, METILAÇÃO DE DNA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Tathiane Maistro Malta et al. Glioma immune microenvironment change during tumor recurrence. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-2717. Acesso em: 10 maio 2024. , 2021
APA
Pereira, T. M. M., Datta, I., Sabedot, T., She, R., Castro, A. V., Iavarone, A., et al. (2021). Glioma immune microenvironment change during tumor recurrence. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-2717
NLM
Pereira TMM, Datta I, Sabedot T, She R, Castro AV, Iavarone A, Poisson LM, Noushmehr H. Glioma immune microenvironment change during tumor recurrence [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2717
Vancouver
Pereira TMM, Datta I, Sabedot T, She R, Castro AV, Iavarone A, Poisson LM, Noushmehr H. Glioma immune microenvironment change during tumor recurrence [Internet]. Cancer Research. 2021 ; 81( 13):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-2717
Artigo de periodico
A serum-based DNA methylation assay provides accurate detection of glioma (2021)
Sabedot, Thais S; Malta, Tathiane M; Snyder, James; Nelson, Kevin; Wells, Michael; Carvalho, Ana C. de; Mukherjee, Abir; Chitale, Dhananjay A; Mosella, Maritza S; Sokolov, Artem; Asmaro, Karam P; Robin, Adam; Rosenblum, Mark L; Mikkelsen, Tom; Rock, Jack; Poisson, Laila M; Lee, Ian; Walbert, Tobias; Kalkanis, Steven; Iavarone, Antonio; Castro, Ana Valeria; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: BIOMARCADORES, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais S et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, v. 23, n. 9, p. 1494-1508, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab023. Acesso em: 10 maio 2024.
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. C. de, et al. (2021). A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology, 23( 9), 1494-1508. doi:10.1093/neuonc/noab023
NLM
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab023
Vancouver
Sabedot TS, Malta TM, Snyder J, Nelson K, Wells M, Carvalho AC de, Mukherjee A, Chitale DA, Mosella MS, Sokolov A, Asmaro KP, Robin A, Rosenblum ML, Mikkelsen T, Rock J, Poisson LM, Lee I, Walbert T, Kalkanis S, Iavarone A, Castro AV, Noushmehr H. A serum-based DNA methylation assay provides accurate detection of glioma [Internet]. Neuro-Oncology. 2021 ; 23( 9): 1494-1508.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab023
Artigo de periodico
Predicting master transcription factors from pan-cancer expression data (2021)
Reddy, Jessica; Fonseca, Marcos A. S.; Corona, Rosario I.; Nameki, Robbin; Dezem, Felipe Segato; Klein, Isaac A.; Chang, Heidi; Moreira, Daniele Chaves; Sabedot, Thais Sarraf; Noushmehr, Houtan; Lawrenson, Kate
Source: Science Advances. Unidade: FMRP
Subjects: CARCINOGÊNESE, NEOPLASIAS OVARIANAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REDDY, Jessica et al. Predicting master transcription factors from pan-cancer expression data. Science Advances, v. 7, n. 48, p. 1-20, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciadv.abf6123. Acesso em: 10 maio 2024.
APA
Reddy, J., Fonseca, M. A. S., Corona, R. I., Nameki, R., Dezem, F. S., Klein, I. A., et al. (2021). Predicting master transcription factors from pan-cancer expression data. Science Advances, 7( 48), 1-20. doi:10.1126/sciadv.abf6123
NLM
Reddy J, Fonseca MAS, Corona RI, Nameki R, Dezem FS, Klein IA, Chang H, Moreira DC, Sabedot TS, Noushmehr H, Lawrenson K. Predicting master transcription factors from pan-cancer expression data [Internet]. Science Advances. 2021 ; 7( 48): 1-20.[citado 2024 maio 10 ] Available from: https://doi.org/10.1126/sciadv.abf6123
Vancouver
Reddy J, Fonseca MAS, Corona RI, Nameki R, Dezem FS, Klein IA, Chang H, Moreira DC, Sabedot TS, Noushmehr H, Lawrenson K. Predicting master transcription factors from pan-cancer expression data [Internet]. Science Advances. 2021 ; 7( 48): 1-20.[citado 2024 maio 10 ] Available from: https://doi.org/10.1126/sciadv.abf6123
Artigo de periodico
A global metagenomic map of urban microbiomes and antimicrobial resistance (2021)
Danko, David; Bezdan, Daniela; Afshin, Evan E.; Ahsanuddin, Sofia; Bhattacharya, Chandrima; Butler, Daniel J.; Chng, Kern Rei; Donnellan, Daisy; Hecht, Jochen; Noushmehr, Houtan
Source: Cell. Unidade: FMRP
Subjects: AGENTES ANTIMICROBIANOS, SEQUENCIAMENTO GENÉTICO, BIOMARCADORES, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANKO, David et al. A global metagenomic map of urban microbiomes and antimicrobial resistance. Cell, v. 184, n. 13, p. 3376-3393, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2021.05.002. Acesso em: 10 maio 2024.
APA
Danko, D., Bezdan, D., Afshin, E. E., Ahsanuddin, S., Bhattacharya, C., Butler, D. J., et al. (2021). A global metagenomic map of urban microbiomes and antimicrobial resistance. Cell, 184( 13), 3376-3393. doi:10.1016/j.cell.2021.05.002
NLM
Danko D, Bezdan D, Afshin EE, Ahsanuddin S, Bhattacharya C, Butler DJ, Chng KR, Donnellan D, Hecht J, Noushmehr H. A global metagenomic map of urban microbiomes and antimicrobial resistance [Internet]. Cell. 2021 ; 184( 13): 3376-3393.[citado 2024 maio 10 ] Available from: https://doi.org/10.1016/j.cell.2021.05.002
Vancouver
Danko D, Bezdan D, Afshin EE, Ahsanuddin S, Bhattacharya C, Butler DJ, Chng KR, Donnellan D, Hecht J, Noushmehr H. A global metagenomic map of urban microbiomes and antimicrobial resistance [Internet]. Cell. 2021 ; 184( 13): 3376-3393.[citado 2024 maio 10 ] Available from: https://doi.org/10.1016/j.cell.2021.05.002
Artigo de periodico
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features (2021)
Mosella, Maritza Queiroz Salas ; Sabedot, Thais Sarraf; Silva, Tiago Chedraoui ; Malta, Tathiane Maistro; Dezem, Felipe Segato; Asmaro, Karam P; Wells, Michael; Mukherjee, Abir; Poisson, Laila M; Snyder, James; Carvalho, Ana C. de; Walbert, Tobias; Aho, Todd; Kalkanis, Steven; Elias, Paula Conde Lamparelli ; Antonini, Sonir Roberto Rauber ; Rock, Jack; Noushmehr, Houtan ; Castro, Margaret de ; Castro, Ana Valéria
Source: Neuro-Oncology. Unidade: FMRP
Subjects: ESTUDOS DE COORTES, METILAÇÃO DE DNA, NEOPLASIAS HIPOFISÁRIAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology, v. 23, n. 8, p. 1292-1303, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab044. Acesso em: 10 maio 2024.
APA
Mosella, M. Q. S., Sabedot, T. S., Silva, T. C., Malta, T. M., Dezem, F. S., Asmaro, K. P., et al. (2021). DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology, 23( 8), 1292-1303. doi:10.1093/neuonc/noab044
NLM
Mosella MQS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, Carvalho AC de, Walbert T, Aho T, Kalkanis S, Elias PCL, Antonini SRR, Rock J, Noushmehr H, Castro M de, Castro AV. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1292-1303.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab044
Vancouver
Mosella MQS, Sabedot TS, Silva TC, Malta TM, Dezem FS, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, Carvalho AC de, Walbert T, Aho T, Kalkanis S, Elias PCL, Antonini SRR, Rock J, Noushmehr H, Castro M de, Castro AV. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1292-1303.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab044
Trabalho de evento-resumo periodico
Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2021)
Varn, Frederick; Johnson, Kevin; Wade, Taylor; Malta, Tathiane; Sabedot, Thais; Barthel, Floris; Kim, Hoon; Ahmed, Nazia; Dalta, Indrani; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Meeting & Education Day of the Society for Neuro-Oncology. Unidades: FMRP, FCFRP
Subjects: GLIOMA, PROGNÓSTICO, SEQUÊNCIA DO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noab196.008. Acesso em: 10 maio 2024. , 2021
APA
Varn, F., Johnson, K., Wade, T., Malta, T., Sabedot, T., Barthel, F., et al. (2021). Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noab196.008
NLM
Varn F, Johnson K, Wade T, Malta T, Sabedot T, Barthel F, Kim H, Ahmed N, Dalta I, Noushmehr H. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment [Internet]. Neuro-Oncology. 2021 ; 23 vi3.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab196.008
Vancouver
Varn F, Johnson K, Wade T, Malta T, Sabedot T, Barthel F, Kim H, Ahmed N, Dalta I, Noushmehr H. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment [Internet]. Neuro-Oncology. 2021 ; 23 vi3.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab196.008
Trabalho de evento-resumo periodico
Apollo: Raman-based pathology of malignant glioma (2021)
Lita, Adrian; Sjöberg, Joel; Filipescu, Stefan; Celiku, Orieta; Petre, Luigia; Gilbert, Mark; Noushmehr, Houtan; Petre, Ion; Larion, Mioara
Source: Neuro-Oncology. Conference titles: Annual Meeting & Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, METILAÇÃO DE DNA, ESPECTROSCOPIA RAMAN
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LITA, Adrian et al. Apollo: Raman-based pathology of malignant glioma. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noab196.497. Acesso em: 10 maio 2024. , 2021
APA
Lita, A., Sjöberg, J., Filipescu, S., Celiku, O., Petre, L., Gilbert, M., et al. (2021). Apollo: Raman-based pathology of malignant glioma. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noab196.497
NLM
Lita A, Sjöberg J, Filipescu S, Celiku O, Petre L, Gilbert M, Noushmehr H, Petre I, Larion M. Apollo: Raman-based pathology of malignant glioma [Internet]. Neuro-Oncology. 2021 ; 23 vi125.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab196.497
Vancouver
Lita A, Sjöberg J, Filipescu S, Celiku O, Petre L, Gilbert M, Noushmehr H, Petre I, Larion M. Apollo: Raman-based pathology of malignant glioma [Internet]. Neuro-Oncology. 2021 ; 23 vi125.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab196.497
Artigo de periodico
Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis (2021)
Datta, Indrani; Noushmehr, Houtan ; Brodie, Chaya; Poisson, Laila M.
Source: Journal of Translational Medicine. Unidade: FMRP
Subjects: REGULAÇÃO NEOPLÁSICA DA EXPRESSÃO GÊNICA, GLIOMA, MICRORNAS, FENÓTIPOS, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DATTA, Indrani et al. Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis. Journal of Translational Medicine, v. 19, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1186/s12967-021-02844-z. Acesso em: 10 maio 2024.
APA
Datta, I., Noushmehr, H., Brodie, C., & Poisson, L. M. (2021). Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis. Journal of Translational Medicine, 19( 1). doi:10.1186/s12967-021-02844-z
NLM
Datta I, Noushmehr H, Brodie C, Poisson LM. Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis [Internet]. Journal of Translational Medicine. 2021 ; 19( 1):[citado 2024 maio 10 ] Available from: https://doi.org/10.1186/s12967-021-02844-z
Vancouver
Datta I, Noushmehr H, Brodie C, Poisson LM. Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis [Internet]. Journal of Translational Medicine. 2021 ; 19( 1):[citado 2024 maio 10 ] Available from: https://doi.org/10.1186/s12967-021-02844-z
Artigo de periodico
Loss of H3K27me3 in meningiomas (2021)
Nassir, Farshad; Wang, Justin Z.; Singh, Olivia; Karimi, Shirin; Dalcourt, Tatyana; Ijad, Nazanin; Pirouzmand, Neda; Ng, Ho-Keung; Saladino, Andrea; Noushmehr, Houtan
Source: Neuro-Oncology. Unidade: FMRP
Subjects: NEOPLASIAS MENÍNGEAS, MENINGIOMA, RECIDIVA LOCAL DE NEOPLASIA, REPRODUTIBILIDADE DE RESULTADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASSIR, Farshad et al. Loss of H3K27me3 in meningiomas. Neuro-Oncology, v. 23, n. 8, p. 1282-1291, 2021Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noab036. Acesso em: 10 maio 2024.
APA
Nassir, F., Wang, J. Z., Singh, O., Karimi, S., Dalcourt, T., Ijad, N., et al. (2021). Loss of H3K27me3 in meningiomas. Neuro-Oncology, 23( 8), 1282-1291. doi:10.1093/neuonc/noab036
NLM
Nassir F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng H-K, Saladino A, Noushmehr H. Loss of H3K27me3 in meningiomas [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1282-1291.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab036
Vancouver
Nassir F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng H-K, Saladino A, Noushmehr H. Loss of H3K27me3 in meningiomas [Internet]. Neuro-Oncology. 2021 ; 23( 8): 1282-1291.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noab036
Trabalho de evento-resumo periodico
Glioma cell-free DNA methylation marker for diagnosis and monitoring (2020)
Sabedot, Thais; Malta, Tathiane Maistro; Snyder, James; Nelson, Kevin; Wells, Michael; Carvalho, Ana de; Mukherjee, Abir; Chitale, Dhan; Mosella, Maritza Queiroz Salas ; Castro, Ana Valéria; Noushmehr, Houtan
Source: Clinical Cancer Research. Conference titles: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Subjects: BIOMARCADORES, METILAÇÃO DE DNA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais et al. Glioma cell-free DNA methylation marker for diagnosis and monitoring. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A10. Acesso em: 10 maio 2024. , 2020
APA
Sabedot, T., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. de, et al. (2020). Glioma cell-free DNA methylation marker for diagnosis and monitoring. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A10
NLM
Sabedot T, Malta TM, Snyder J, Nelson K, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella MQS, Castro AV, Noushmehr H. Glioma cell-free DNA methylation marker for diagnosis and monitoring [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A10
Vancouver
Sabedot T, Malta TM, Snyder J, Nelson K, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella MQS, Castro AV, Noushmehr H. Glioma cell-free DNA methylation marker for diagnosis and monitoring [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A10
Trabalho de evento-resumo periodico
Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication (2020)
Wong, Queenie Hoi-Wing; Wong, Gabriel Chun-Hei; Chan, Aden Ka-Yin; Poon, Wai Sang; Chan, Danny Tat-Ming; Chen, Hong; Zhang, Zhen-yu; Noushmehr, Houtan ; Jones, Chris; Grabovska, Yura; Mackay, Alan; Chow, Chit; Kwan, Johnny Sheung Him; Chung, Nellie Yuk-Fei; Huang, Queenie Junqi; Poon, Manix Fung-Man; Shi, Zhi-feng; Li, Kay Ka-Wai; Ng, Ho-Keung
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, SEQUENCIAMENTO GENÉTICO, RNA, GENÔMICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WONG, Queenie Hoi-Wing et al. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.704. Acesso em: 10 maio 2024. , 2020
APA
Wong, Q. H. -W., Wong, G. C. -H., Chan, A. K. -Y., Poon, W. S., Chan, D. T. -M., Chen, H., et al. (2020). Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.704
NLM
Wong QH-W, Wong GC-H, Chan AK-Y, Poon WS, Chan DT-M, Chen H, Zhang Z-yu, Noushmehr H, Jones C, Grabovska Y, Mackay A, Chow C, Kwan JSH, Chung NY-F, Huang QJ, Poon MF-M, Shi Z-feng, Li KK-W, Ng H-K. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication [Internet]. Neuro-Oncology. 2020 ; 22 ii169.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noaa215.704
Vancouver
Wong QH-W, Wong GC-H, Chan AK-Y, Poon WS, Chan DT-M, Chen H, Zhang Z-yu, Noushmehr H, Jones C, Grabovska Y, Mackay A, Chow C, Kwan JSH, Chung NY-F, Huang QJ, Poon MF-M, Shi Z-feng, Li KK-W, Ng H-K. Genomic landscape of idh-mutant primary glioblastomas shows distinct clinical and molecular features and that CDKN2A should be supplemented with MGMTp and G-CIMP for precise prognostication [Internet]. Neuro-Oncology. 2020 ; 22 ii169.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noaa215.704
Artigo de periodico
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas (2020)
Ruiz-Rodado, Victor; Malta, Tathiane Maistro; Seki, Tomohiro; Lita, Adrian; Dowdy, Tyrone; Celiku, Orieta; Cavazos-Saldana, Alejandra; Li, Aiguo; Liu, Yang; Han, Sue; Zhang, Wei; Song, Hua; Davis, Dionne; Lee, Sunmin; Trepel, Jane B.; Sabedot, Thais Sarraf; Munasinghe, Jeeva; Yang, Chunzhang; Herold-Mende, Christel; Gilbert, Mark R.; Cherukuri, Murali Krishna; Noushmehr, Houtan; Larion, Mioara
Source: Neuro-Oncology. Unidades: FCFRP, FMRP
Subjects: MUTAÇÃO GENÉTICA, GLIOMA, EPIGÊNESE GENÉTICA, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ-RODADO, Victor et al. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas. Neuro-Oncology, v. 22, n. 4, p. 480-492, 2020Tradução . . Disponível em: https://doi.org/10.1093/neuonc/noz207. Acesso em: 10 maio 2024.
APA
Ruiz-Rodado, V., Malta, T. M., Seki, T., Lita, A., Dowdy, T., Celiku, O., et al. (2020). Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas. Neuro-Oncology, 22( 4), 480-492. doi:10.1093/neuonc/noz207
NLM
Ruiz-Rodado V, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, Sabedot TS, Munasinghe J, Yang C, Herold-Mende C, Gilbert MR, Cherukuri MK, Noushmehr H, Larion M. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas [Internet]. Neuro-Oncology. 2020 ; 22( 4): 480-492.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz207
Vancouver
Ruiz-Rodado V, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, Sabedot TS, Munasinghe J, Yang C, Herold-Mende C, Gilbert MR, Cherukuri MK, Noushmehr H, Larion M. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas [Internet]. Neuro-Oncology. 2020 ; 22( 4): 480-492.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noz207
Trabalho de evento-resumo periodico
DNA methylation-based liquid biopsy detects primary and recurrent meningioma (2020)
Sabedot, Thais Sarraf; Malta, Tathiane M.; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Source: Clinical Cancer Research. Conference titles: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Subjects: BIÓPSIA, METILAÇÃO DE DNA, MENINGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. DNA methylation-based liquid biopsy detects primary and recurrent meningioma. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A12. Acesso em: 10 maio 2024. , 2020
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2020). DNA methylation-based liquid biopsy detects primary and recurrent meningioma. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A12
NLM
Sabedot TS, Malta TM, Snyder J, Walbert T, Lee I, Kalkanis S, Castro AV, Noushmehr H. DNA methylation-based liquid biopsy detects primary and recurrent meningioma [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A12
Vancouver
Sabedot TS, Malta TM, Snyder J, Walbert T, Lee I, Kalkanis S, Castro AV, Noushmehr H. DNA methylation-based liquid biopsy detects primary and recurrent meningioma [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A12
Artigo de periodico
Mutated CEACAMs disrupt transforming growth factor beta signaling and alter the intestinal microbiome to promote colorectal carcinogenesis (2020)
Gu, Shoujun; Zaidi, Sobia; Hassan, Imtaiyaz; Mohammad, Taj; Malta, Tathiane Maistro; Noushmehr, Houtan; Nguyen, Bryan; Crandall, Keith A.; Srivastav, Jigisha; Obias, Vincent; Lin, Paul; Nguyen, Bao-Ngoc; Yao, Michael; Yao, Ren; King, Charles Hadley; Mazumder, Raja; Mishra, Bibhuti; Rao, Shuyun; Mishra, Lopa
Source: Gastroenterology. Unidades: FCFRP, FMRP
Subjects: TRANSCRIÇÃO GÊNICA, BACTÉRIAS, GENÉTICA, NEOPLASIAS COLORRETAIS, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GU, Shoujun et al. Mutated CEACAMs disrupt transforming growth factor beta signaling and alter the intestinal microbiome to promote colorectal carcinogenesis. Gastroenterology, v. 158, n. 1, p. 238-252, 2020Tradução . . Disponível em: https://doi.org/10.1053/j.gastro.2019.09.023. Acesso em: 10 maio 2024.
APA
Gu, S., Zaidi, S., Hassan, I., Mohammad, T., Malta, T. M., Noushmehr, H., et al. (2020). Mutated CEACAMs disrupt transforming growth factor beta signaling and alter the intestinal microbiome to promote colorectal carcinogenesis. Gastroenterology, 158( 1), 238-252. doi:10.1053/j.gastro.2019.09.023
NLM
Gu S, Zaidi S, Hassan I, Mohammad T, Malta TM, Noushmehr H, Nguyen B, Crandall KA, Srivastav J, Obias V, Lin P, Nguyen B-N, Yao M, Yao R, King CH, Mazumder R, Mishra B, Rao S, Mishra L. Mutated CEACAMs disrupt transforming growth factor beta signaling and alter the intestinal microbiome to promote colorectal carcinogenesis [Internet]. Gastroenterology. 2020 ; 158( 1): 238-252.[citado 2024 maio 10 ] Available from: https://doi.org/10.1053/j.gastro.2019.09.023
Vancouver
Gu S, Zaidi S, Hassan I, Mohammad T, Malta TM, Noushmehr H, Nguyen B, Crandall KA, Srivastav J, Obias V, Lin P, Nguyen B-N, Yao M, Yao R, King CH, Mazumder R, Mishra B, Rao S, Mishra L. Mutated CEACAMs disrupt transforming growth factor beta signaling and alter the intestinal microbiome to promote colorectal carcinogenesis [Internet]. Gastroenterology. 2020 ; 158( 1): 238-252.[citado 2024 maio 10 ] Available from: https://doi.org/10.1053/j.gastro.2019.09.023
Trabalho de evento-resumo periodico
Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features (2020)
Wells, Michael; Asmaro, karam; Sabedot, Thais; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Source: Clinical Cancer Research. Conference titles: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Subjects: METILAÇÃO DE DNA, GLÂNDULA PITUITÁRIA, NEOPLASIAS, BIÓPSIA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A11. Acesso em: 10 maio 2024. , 2020
APA
Wells, M., Asmaro, karam, Sabedot, T., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2020). Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A11
NLM
Wells M, Asmaro karam, Sabedot T, Mosella MQS, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A11
Vancouver
Wells M, Asmaro karam, Sabedot T, Mosella MQS, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 maio 10 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A11
Trabalho de evento-resumo periodico
Epigenomics of the glioma longitudinal analysis (glass) consortium (2020)
Sabedot, Thais; Wells, Michael; Datta, Indrani; Malta, Tathiane; Castro, Ana Valeria; Poisson, Laila M; Verhaak, Roel; Iavarone, Antonio; Noushmehr, Houtan
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais et al. Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.308. Acesso em: 10 maio 2024. , 2020
APA
Sabedot, T., Wells, M., Datta, I., Malta, T., Castro, A. V., Poisson, L. M., et al. (2020). Epigenomics of the glioma longitudinal analysis (glass) consortium. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.308
NLM
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Vancouver
Sabedot T, Wells M, Datta I, Malta T, Castro AV, Poisson LM, Verhaak R, Iavarone A, Noushmehr H. Epigenomics of the glioma longitudinal analysis (glass) consortium [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii75.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noaa215.308
Trabalho de evento-resumo periodico
Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon (2020)
Tesileanu, C. Mircea S.; Van den Bent, Martin; Sabedot, Thais; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Erridge, Sarah; Vogelbaum, Michael; Nowak, Anna; Baurain, Jean; Mason, Warren; Wheeler, Helen; Weller, Michael; Heer, Iris de; Dubbink, Hendrikus; Kros, Johan M; Aldape, Kenneth; Wesseling, Pieter; Golfinopoulos, Vassilis; Gorlia, Thierry; Baumert, Brigitta; Noushmehr, Houtan ; French, Pim
Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.693. Acesso em: 10 maio 2024. , 2020
APA
Tesileanu, C. M. S., Van den Bent, M., Sabedot, T., Sanson, M., Brandes, A., Wick, W., et al. (2020). Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.693
NLM
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693
Vancouver
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 maio 10 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration